Document is current
Any future updates will be listed below
-
Authors
Yin, Xiangyun
Zhang, Sophia https://orcid.org/0009-0003-6412-9305
Lee, Ju Hyun https://orcid.org/0000-0001-6728-2071
Dong, Huiping
Mourgkos, George
Terwilliger, Gordon
Kraus, Aurora
Geraldo, Luiz Henrique https://orcid.org/0000-0003-3318-4697
Poulet, Mathilde https://orcid.org/0000-0002-2216-4132
Fischer, Suzanne
Zhou, Ting https://orcid.org/0000-0001-8783-8380
Mohammed, Farrah Shalima
Zhou, Jiangbing https://orcid.org/0000-0002-1201-5360
Wang, Yongfu https://orcid.org/0000-0003-3499-0586
Malloy, Seth
Rohner, Nicolas https://orcid.org/0000-0003-3248-2772
Sharma, Lokesh https://orcid.org/0000-0003-3040-9029
Salinas, Irene
Eichmann, Anne
Thomas, Jean-Leon https://orcid.org/0000-0003-3397-0292
Saltzman, W. Mark https://orcid.org/0000-0002-2163-549X
Huttner, Anita
Zeiss, Caroline
Ring, Aaron https://orcid.org/0000-0003-3699-2446
Iwasaki, Akiko https://orcid.org/0000-0002-7824-9856
Song, Eric https://orcid.org/0000-0001-5448-5865
- License Information
-
More Information
Article History
Received: 26 October 2022
Accepted: 29 January 2024
First Online: 28 February 2024
Competing interests
: E.S., A.R. and A.I. are co-founders of Rho Bio. A.I. is a member of the Board of Directors of Roche Holding Ltd. E.S., J.-L.T. and A.I. are co-inventors on patent application No. 62/929,527, “Manipulation of meningeal lymphatic vasculature for brain and CNS tumour therapy”. W.M.S. is a co-founder of B3 Therapeutics, Stradefy and Xanadu Bio. W.M.S. is a consultant to Xanadu Bio, Stradefy Biosciences, Johnson & Johnson, Celanese, Cranius and CMC Pharma.
